Age-related Macular Degeneration (AMD) is the leading cause of irreversible blindness in the industrialized world, affecting over 10 million individuals in North America. A study lead by Dr. Przemyslaw (Mike) Sapieha, researcher ...
Nov 15, 2016
0
9
The discovery of a novel protein that links aging and age-dependent retinal diseases could lead to potential new treatments for conditions that cause sight loss in later life.
Nov 15, 2016
0
44
The number of cases of macular disease without a clear diagnosis could be halved under an innovative system that first refers patients to an optometrist, UNSW research shows.
Nov 1, 2016
0
0
In the past decade, ophthalmologists have been prescribing nutritional supplements to be taken daily to prevent or slow vision loss from age-related macular degeneration (AMD). Now, using nutritional supplements for eye health ...
Oct 27, 2016
0
40
The long-term safety of gene transfer to treat neovascular age-related macular degeneration (NVAMD), and the production of two therapeutic proteins encoded by those genes for at least 2.5 years in the eyes of patients with ...
Oct 20, 2016
0
1
People who closely follow the Mediterranean diet - -especially by eating fruit—may be more than a third less likely to develop age-related macular degeneration, a leading cause of blindness, according to a study presented ...
Oct 17, 2016
0
2
An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation.
Oct 14, 2016
0
1
New research published in Cell Reports identifies a potential treatment target for blinding diseases such as retinitis pigmentosa and advanced dry age-related macular degeneration. In the study, researchers at Washington ...
Sep 28, 2016
0
14
Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions—but ...
Jul 27, 2016
0
29
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision ...
Jul 20, 2016
0
85
